Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agentsRAJIV KUMAR TONK; BAWA, Sandhya; CHAWLA, Gita et al.European journal of medicinal chemistry. 2012, Vol 57, pp 176-184, issn 0223-5234, 9 p.Article

Selective regulation of aromatase expression for drug discoveryBRUEGGEMEIER, Robert W; BIN SU; DARBY, Michael V et al.Journal of steroid biochemistry and molecular biology. 2010, Vol 118, Num 4-5, pp 207-210, issn 0960-0760, 4 p.Conference Paper

NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2AMIRGHAHARI, Nazanin; HARRISON, Lynn; SMITH, Melanie et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 5, pp 1405-1412, issn 0360-3016, 8 p.Article

The impact of selective and non-selective non-steroid anti-inflammatory drugs on secondary hemostasis in healthy volunteersSCHJERNING, Ole; LARSEN, Torben B; DAMKIER, Per et al.Thrombosis research. 2009, Vol 124, Num 2, pp 208-212, issn 0049-3848, 5 p.Article

Drug-Induced Thrombosis-Experimental, Clinical, and Mechanistic ConsiderationsRAMOT, Yuval; NYSKA, Abraham.Toxicologic pathology. 2007, Vol 35, Num 2, pp 208-227, issn 0192-6233, 20 p.Article

Advances in breast oncology: The 2002 ASCO MeetingSINGH-RANGER, G; MOKBEL, K.Current medical research and opinion. 2002, Vol 18, Num 7, pp 401-406, issn 0300-7995, 6 p.Article

Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitorsJAWABRAH AL-HOURANI, Baker; KIRAN SHARMA, Sai; SURESH, Mavanur et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 6, pp 2235-2238, issn 0960-894X, 4 p.Article

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysisCHAN, Clara C; REID, Christopher M; AW, Tai-Juan et al.Journal of hypertension. 2009, Vol 27, Num 12, pp 2332-2341, issn 0263-6352, 10 p.Article

The efficacy of preoperative versus postoperative rofecoxib for preventing acute postoperative dental pain : A prospective randomized crossover study using bilateral symmetrical oral surgeryONG, K. S; SEYMOUR, R. A; YEO, J. F et al.The Clinical journal of pain. 2005, Vol 21, Num 6, pp 536-542, issn 0749-8047, 7 p.Article

Osteoarthritis: the impact of a serious diseaseBREEDVELD, F. C.Rheumatology (Oxford. Print). 2004, Vol 43, pp i4-i8, issn 1462-0324, SUP1Article

Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: Preclinical basisMILAS, Luka.American journal of clinical oncology. 2003, Vol 26, Num 4, pp 66-69, issn 0277-3732, 4 p., SUP2Conference Paper

Nonsteroidal Antiinflammatory Drug Use and Cardiovascular Risks After Coronary Stent ImplantationSCHMIDT, Morten; PEDERSEN, Lars; MAENG, Michael et al.Pharmacotherapy. 2011, Vol 31, Num 5, pp 458-468, issn 0277-0008, 11 p.Article

Heterotopic ossification in burns: Our experience and literature reviewsCHEN, Hung-Chang; YANG, Jui-Yung; CHUANG, Shiow-Shuh et al.Burns. 2009, Vol 35, Num 6, pp 857-862, issn 0305-4179, 6 p.Article

Comparison of Analgesic and Anti-Inflammatory Efficacy of Selective and Non-Selective Cyclooxygenase-2 Inhibitors in Dental Implant SurgeryKARABUDA, Zihni Cuneyt; BOLUKBASI, Nilufer; ARAL, Ali et al.Journal of periodontology. 2007, Vol 78, Num 12, pp 2284-2288, issn 0022-3492, 5 p.Article

Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsBEHAN, K; CUTTS, C; TETT, S. E et al.Journal of clinical pharmacy and therapeutics (Print). 2005, Vol 30, Num 4, pp 337-343, issn 0269-4727, 7 p.Article

An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matricesNAGESWARA RAO, R; MEENA, S; RAGHURAM RAO, A et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 3-4, pp 349-363, issn 0731-7085, 15 p.Article

Clinical use and pharmacological properties of selective COX-2 inhibitorsSHAOJUN SHI; KLOTZ, Ulrich.European journal of clinical pharmacology. 2008, Vol 64, Num 3, pp 233-252, issn 0031-6970, 20 p.Article

Possible Link between History of Hypersensitivity to a Specific Non-steroidal Anti-inflammatory Drug (NSAID) and Positive Results Following Challenge Test to Alternative NSAIDsTROMBETTA, Domenico; IMBESI, Selene; VITA, Giuseppe et al.Arzneimittel-Forschung. 2009, Vol 59, Num 8, pp 410-414, issn 0004-4172, 5 p.Article

SAR: Flavonoids and COX-2 inhibitionROSENKRANZ, Herbert S; THAMPATTY, Bhavani P.Oncology research. 2003, Vol 13, Num 12, pp 529-535, issn 0965-0407, 7 p.Article

Mechanism of K_v2.1 channel inhibition by a selective COX-2 inhibitor SC—791—modification of gatingFROLOV, Roman V; IGNATOVA, Irina I; SINGH, Satpal et al.Brain research. 2010, Vol 1359, pp 67-74, issn 0006-8993, 8 p.Article

Effects of indomethacin and celecoxib on renal function in athletesBAKER, Jordan; COTTER, James D; GERRARD, David F et al.Medicine and science in sports and exercise. 2005, Vol 37, Num 5, pp 712-717, issn 0195-9131, 6 p.Article

Review of the applications of different analytical techniques for coxibs researchSTAREK, Małgorzata.Talanta (Oxford). 2011, Vol 85, Num 1, pp 8-27, issn 0039-9140, 20 p.Article

Incidence and Possible Risk Factors for Clinical Upper Gastrointestinal Events in Patients Taking Selective Cyclooxygenase-2 Inhibitors: A Prospective, Observational, Cohort Study in TaiwanHSIANG, Kuo-Wei; CHEN, Tseng-Shing; LIN, Hsiao-Yi et al.Clinical therapeutics. 2010, Vol 32, Num 7, pp 1294-1303, issn 0149-2918, 10 p.Article

What therapies have replaced rofecoxib in Ireland?TEELING, Mary; O'CONNOR, Humphrey; FEELY, John et al.British journal of clinical pharmacology. 2007, Vol 64, Num 4, pp 536-541, issn 0306-5251, 6 p.Article

The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in ScotlandWILLIAMS, D; SINGH, M; HIND, C et al.British journal of clinical pharmacology. 2006, Vol 62, Num 3, pp 366-368, issn 0306-5251, 3 p.Article